SCHEMBL5577945

SCHEMBL5577945

CN(C)C(=O)COc1ccc(C=O)c(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.49
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
TP53 P04637 1/20 0.48
HPGD P15428 1/20 0.48
HSD17B10 Q99714 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
PKM P14618 1/20 0.47
RAB9A P51151 3/20 0.46
NPC1 O15118 2/20 0.46
PDK2 Q15119 1/20 0.43
POLB P06746 1/20 0.42
MCL1 Q07820 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
LOXL2 Q9Y4K0 2/20 0.42
KEAP1 Q14145 2/20 0.42
NFE2L2 Q16236 2/20 0.42
ERN1 O75460 1/20 0.42
ACSS2 Q9NR19 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14455036 0.86 NPC1 (0.51) SMN1; SMN2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL23804143 0.82 MCL1 (0.58) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL7682886 0.81 PTGS2 (0.54) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL1250815 0.81 SMN1; SMN2 (0.45) SMN1; SMN2KDM4EALDH1A1TP53HPGD
SCHEMBL4697986 0.81 ALDH1A1 (0.56) ALDH1A1PDK2POLBMCL1ERN1
SCHEMBL14455038 0.80 ALDH1A1 (0.46) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL6319246 0.80 ERN1 (0.54) SMN1; SMN2KDM4EALDH1A1TP53HPGD
SCHEMBL30087228 0.78 PSEN1 (0.42) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL14455033 0.78 PSEN1 (0.42) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL1647021 0.77 KDM4E (0.53) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed
WO-2007059341-A2 PYRAZOLOTHIAZOLE PROTEIN KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2007-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators MAP4K2, MAP4K5, MAP4K3 SMN1; SMN2 3826/4885KDM4E 1377/4885ALDH1A1 3700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.